Atlas Trials

Maintenance Niraparib and Dostarlimab in Advanced Cholangiocarcinoma

Clinical trial NCT04895046 · WITHDRAWN

Trial details

NCT number
NCT04895046
Sponsor
Walid Shaib, MD
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
HRDCholangiocarcinomaMetastatic Cancer
Start date
2021-10-11
Primary completion
2022-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.